Likewise, we could not detect lower gene expression of hepatic collagen I (Col1a1 and Col1a2) or other liver fibrosis-promoting genes such as Lox25 or Timp126 in any of the dose groups evaluated (Fig. 2c). The gene discussed is COL1A2; the disease is Hepatic fibrosis.